Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Can J Physiol Pharmacol ; 98(8): 522-530, 2020 Aug.
Article de Anglais | MEDLINE | ID: mdl-32729719

RÉSUMÉ

Acute lung injury (ALI), a disease with a high mortality rate, is a noncardiogenic pulmonary inflammatory response and characterized by damage to the pulmonary system. In this study, we explored the mechanism of the occurrence and development of ALI. It was firstly found that miR-138-5p could inhibit the expression of sirtuin1 (SIRT1), and we further demonstrated that miR-138-5p targets directly SIRT1 through the luciferase assay, while the latter negatively regulated the expression of NF-κB. A549 cells were treated with lipopolysaccharide in vitro to simulate ALI cells and induce ALI in the model mice. The results showed that inhibiting the expression of miR-138-5p could effectively increase the viability of damaged cells, promote cell proliferation, reduce apoptosis, inhibit the inflammatory response, reduce oxidative stress, and then relieve ALI symptoms. Collectively, our results suggested that miR-138-5p can inhibit SIRT1 expression and indirectly activate the NF-κB signaling pathway, thus regulating the development of ALI.


Sujet(s)
Lésion pulmonaire aigüe/génétique , Lésion pulmonaire aigüe/anatomopathologie , microARN/génétique , Facteur de transcription NF-kappa B/métabolisme , Transduction du signal/génétique , Sirtuine-1/génétique , Cellules A549 , Animaux , Apoptose/génétique , Prolifération cellulaire/génétique , Survie cellulaire/génétique , Régulation de l'expression des gènes , Humains , Mâle , Souris de lignée C57BL
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE